OpenAlex
PricingAboutJobs
Log inGet started
Work

RNA-targeting and gene editing therapies for transthyretin amyloidosis

HTML

Year: 2022
Type: review
Source: Nature Reviews Cardiology
DOI: 10.1038/s41569-022-00683-z
Authors: Alberto Aimo, Vincenzo Castiglione, Claudio Rapezzi, Maria Franzini, Giorgia Panichella, Giuseppe Vergaro, Julian Gillmore, Marianna Fontana, Claudio Passino, Michele Emdin
Institutions: Scuola Superiore Sant'Anna, Fondazione Toscana Gabriele Monasterio, University of Ferrara, Maria Cecilia Hospital, University of Pisa, Azienda Ospedaliera Universitaria Pisana, The Royal Free Hospital, University College London
Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Keywords: transthyretin amyloidosis, prealbumin, siRNA, antisense oligonucleotides, patisiran, inotersen, vutrisiran, CRISPR/Cas9 genome editing, transthyretin amyloid cardiomyopathy
SDG: Good health and well-being

Open Access status: green

Funder: British Heart Foundation
Award: The pathophysiology of cardiac AL amyloidosis: phenotypic spectrum and clinical significance
OpenAlex ID: W4220826461
FWCI: 7.681
Cites: 88
Cited by: 181
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security